Publicaciones (165) Publicaciones de María Dolores Lozano Escario

2023

  1. A brief review of the WHO reporting system for pancreaticobiliary cytopathology

    Journal of the American Society of Cytopathology, Vol. 12, Núm. 4, pp. 243-250

  2. Characterization of the immune infiltrate in mouse tissue by multiplex immunofluorescence

    Methods in Cell Biology, Vol. 174, pp. 43-53

  3. Correction to: New update to the guidelines on testing predictive biomarkers in non‑small‑cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology (Clinical and Translational Oncology, (2022), 10.1007/s12094-022-03046-9)

    Clinical and Translational Oncology

  4. Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non-Small-Cell Lung Cancer

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 14, pp. 2561-2570

  5. Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108

  6. Medullary Thyroid Carcinoma

    The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes, Third Edition (Springer International Publishing), pp. 177-196

  7. Modification of Breast Cancer Milieu with Chemotherapy plus Dendritic Cell Vaccine: An Approach to Select Best Therapeutic Strategies

    Biomedicines, Vol. 11, Núm. 2

  8. Molecular/biomarker testing in lung cytology: A practical approach

    Diagnostic Cytopathology, Vol. 51, Núm. 1, pp. 59-67

  9. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1252-1267

  10. New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia, Vol. 56, Núm. 2, pp. 97-112

  11. Overview and update on molecular testing in non-small cell lung carcinoma utilizing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) samples

    Diagnostic Cytopathology, Vol. 51, Núm. 1, pp. 26-35

  12. Pathologist-initiated reflex testing for biomarkers in non-small-cell lung cancer: expert consensus on the rationale and considerations for implementation

    ESMO Open, Vol. 8, Núm. 4

  13. Recommendations for optimizing the use of cytology in the diagnosis and management of patients with lung cancer

    Revista Espanola de Patologia, Vol. 56, Núm. 1, pp. 58-68

  14. Reference standards for gene fusion molecular assays on cytological samples: an international validation study

    Journal of clinical pathology, Vol. 76, Núm. 1, pp. 47-52